Eppendorf Array Technologies licenses IPA for internal projects supporting new company research efforts.
Redwood City, CA – June 13, 2006 – Ingenuity Systems and Eppendorf Array Technologies SA, an affiliate of the Eppendorf Group, today announced that they have entered into a licensing agreement for IPA software. Under the new terms, Eppendorf will use IPA for internal development and special projects for key accounts and service providers.
“Our objective is to provide our internal teams with the very best products available so they can develop micro arrays with the excellent content,” said José Remacle, General Manager, Eppendorf Array Technologies SA. “Through this agreement, we will be able to utilize IPA, ensuring our data analysis and pathway modeling is a straightforward and robust process. This is an example of our interest in developing creative approaches that identify optimized solutions to suite our internal teams needs.”
IPA is a software application that enables researchers to model, analyze and understand the complex biological systems at the core of life science research. IPA is deployed in most major pharmaceutical companies and hundreds of biotechnology companies and academic institutions globally. It supports analysis of all high throughput analysis platforms and is used in virtually all areas of drug discovery and development from target identification and validation to biomarkers, predictive toxicology, and pharmacogenomics.
IPA is available as a web-delivered, hosted, or deployed solution. Fully functional complimentary trials are available at www.ingenuity.com/trial/start.html.
About Eppendorf AG
The Eppendorf AG, based in Hamburg, Germany, is a leading supplier of systems and research tools for the biotechnology industry worldwide. Eppendorf manufactures instruments and consumables for liquid handling as well as a range of PCR products including instruments. Other products comprise centrifugation, bio reagents and innovative micro array products, as well as premium products for cell technology research. In the 2004 financial year, Eppendorf employed 1,748 people worldwide and achieved sales of 287 million Euro (approx. 345 million US Dollars) with an operative result (EBIT) of 40.1 million Euro (approx. 48 million US Dollars). More Information about Eppendorf is available at www.eppendorf.com.
About Ingenuity Systems®
Ingenuity enables researchers to model, analyze and understand complex biological systems foundational to human health and disease. The Ingenuity products include pathways analysis software and knowledge bases for biologists and bioinformaticians, and enterprise knowledge management infrastructure, content and services for leading pharmaceutical and biotech companies. Ingenuity was founded in 1998 and is headquartered in Redwood City, California with offices in Germany, Switzerland, France, the United Kingdom, and Japan. www.ingenuity.com.